Alyeska Investment Group
ZVRA icon

Alyeska Investment Group’s Zevra Therapeutics ZVRA Stock Holding History

Alyeska Investment Group’s Portfolio ZVRA Stock Details ZVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-26,721
Closed -$748K – 514
2019
Q2 		$748K Sell
26,721
-67,207
-72% -$1.69M 0.01% 383
2019
Q1 		$2.51M Sell
93,928
-20,135
-18% -$741K 0.03% 269
2018
Q4 		$3.25M Buy
114,063
+92,079
+419% +$3.73M 0.05% 257
2018
Q3 		$1.69M Sell
21,984
-33,246
-60% -$2.6M 0.02% 314
2018
Q2 		$5.74M Sell
55,230
-556
-1% -$54.3K 0.05% 263
2018
Q1 		$7.05M Sell
55,786
-6,235
-10% -$603K 0.06% 261
2017
Q4 		$4.02M Hold
62,021
– – 0.03% 276
2017
Q3 		$3.67M Buy
62,021
+1,107
+2% +$59K 0.03% 314
2017
Q2 		$3.9M Sell
60,914
-1,347
-2% -$88.7K 0.03% 301
2017
Q1 		$4.88M Sell
62,261
-160
-0.3% -$9.72K 0.04% 318
2016
Q4 		$2.95M Buy
62,421
+1,963
+3% +$121K 0.02% 366
2016
Q3 		$4.34M Buy
60,458
+9,666
+19% +$688K 0.04% 332
2016
Q2 		$3.23M Buy
50,792
+24,861
+96% +$4.09M 0.03% 336
2016
Q1 		$6.02M Sell
25,931
-2,096
-7% -$508K 0.06% 273
2015
Q4 		$8.91M Buy
28,027
+9,888
+55% +$2.68M 0.09% 221
2015
Q3 		$5.63M Buy
18,139
+2,092
+13% +$641K 0.07% 242
2015
Q2 		$4.72M Buy
+16,047
New +$3.5M 0.05% 276

Other funds holding ZVRA

DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RFN
RDA Financial Network Akron, Iowa $459M AUM 24.58% 1-Year Est. Return

Alyeska Investment Group's ZVRA Position: Q3 2019 in Review

Alyeska Investment Group sold out of Zevra Therapeutics (ZVRA) in Q3 2019, closing a stake of 26,721 shares — an estimated $748K sold.

Alyeska Investment Group first reported a position in ZVRA in Q2 2015 and held it in 17 quarters. The position peaked at $8.91M in Q4 2015. 38 funds tracked by Wall St. Rank hold ZVRA as of Q3 2019.

  • Alyeska Investment Group reported no remaining Zevra Therapeutics position as of Q3 2019 after selling out during the quarter.
  • Alyeska Investment Group sold 26,721 Zevra Therapeutics shares in Q3 2019, an estimated $748K.
  • Alyeska Investment Group first reported a position in Zevra Therapeutics in Q2 2015 and held it in 17 quarters.
  • Alyeska Investment Group's Zevra Therapeutics position peaked at $8.91M in Q4 2015.
  • 38 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q3 2019.

Based on Alyeska Investment Group's 13F filing for Q3 2019, filed 14 Nov 2019.